These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37180414)

  • 1. End-stage crystalline maculopathy with retinal atrophy in Sjögren-Larsson syndrome: a case report and review of the literature.
    Lambert LH; Shaikh N; Marx JL; Ramsey DJ
    Ther Adv Rare Dis; 2022; 3():26330040221122496. PubMed ID: 37180414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.
    Fouzdar-Jain S; Suh DW; Rizzo WB
    Ophthalmic Genet; 2019 Aug; 40(4):298-308. PubMed ID: 31512987
    [No Abstract]   [Full Text] [Related]  

  • 3. Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.
    Al-Holou SN; Siefker E; Fouzdar-Jain S; Suh DW; Rizzo WB
    Ophthalmic Genet; 2020 Aug; 41(4):381-385. PubMed ID: 32506993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography.
    Fuijkschot J; Cruysberg JR; Willemsen MA; Keunen JE; Theelen T
    Ophthalmology; 2008 May; 115(5):870-5. PubMed ID: 17826835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.
    J SK; Waheed MD; Batool S; Holder SS; Rodriguez Reyes Y; Guntha M
    Cureus; 2023 Feb; 15(2):e35159. PubMed ID: 36950004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Morphology in Sjögren-Larsson Syndrome on OCT: From Metabolic Crystalline Maculopathy to Early-Onset Macular Degeneration.
    Staps P; Cruysberg JRM; Roeleveld N; Willemsen MAAP; Theelen T
    Ophthalmol Retina; 2019 Jun; 3(6):500-509. PubMed ID: 31174672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype and phenotype variability in Sjögren-Larsson syndrome.
    Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
    Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Capillary Abnormalities in Sjögren-Larsson Syndrome Maculopathy.
    Staps P; de Breuk A; Cruysberg JRM; Willemsen M; Theelen T
    Case Rep Ophthalmol; 2022; 13(2):341-349. PubMed ID: 35702653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of Sjogren-Larsson syndrome with recurrent pneumonia and asthma.
    Tavasoli A; Sayyahfar S; Behnam B
    Korean J Pediatr; 2016 Jun; 59(6):276-9. PubMed ID: 27462357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
    Amr K; El-Bassyouni HT; Ismail S; Youness E; El-Daly SM; Ebrahim AY; El-Kamah G
    Arch Dermatol Res; 2019 Nov; 311(9):721-730. PubMed ID: 31388754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
    Cho KH; Shim SH; Kim M
    Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous mutations in the
    Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX
    Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren-Larsson syndrome: optical coherence tomography and a novel mutation.
    Burgueño-Montañés C; García-Fernández M; Colunga-Cueva M; García-López A
    Arch Soc Esp Oftalmol; 2014 Dec; 89(12):504-7. PubMed ID: 24377952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with Sjögren-Larsson syndrome lack macular pigment.
    van der Veen RL; Fuijkschot J; Willemsen MA; Cruysberg JR; Berendschot TT; Theelen T
    Ophthalmology; 2010 May; 117(5):966-71. PubMed ID: 20163870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren-Larsson Syndrome: Mechanisms and Management.
    Bindu PS
    Appl Clin Genet; 2020; 13():13-24. PubMed ID: 32021380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients.
    van Domburg PH; Willemsen MA; Rotteveel JJ; de Jong JG; Thijssen HO; Heerschap A; Cruysberg JR; Wanders RJ; Gabreëls FJ; Steijlen PM
    Neurology; 1999 Apr; 52(7):1345-52. PubMed ID: 10227616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted Metabolomic Analysis of Sjögren-Larsson Syndrome Reveals a Distinctive Pattern of Multiple Disrupted Biochemical Pathways.
    Dai HD; Qiu F; Jackson K; Fruttiger M; Rizzo WB
    Metabolites; 2023 May; 13(6):. PubMed ID: 37367841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.
    Staps P; van Gaalen J; van Domburg P; Steijlen PM; Ferdinandusse S; den Heijer T; Seyger MMB; Theelen T; Willemsen MAAP
    JIMD Rep; 2020 May; 53(1):61-70. PubMed ID: 32395410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.